Roche invests $500 million in Canadian operations site

Oct. 20, 2020

Roche Canada have announced that it is investing into Ontario’s life sciences industry with a facility that will bring up to 500 highly skilled and specialized full-time positions to the province. This $500 million investment over five years will establish Roche’s Global Pharma Technical (PT) Operations site at its Canadian pharmaceutical headquarters in Mississauga. By the end of 2020, Roche will have hired 200 skilled jobs and up to 300 more by the end of 2023.

"Ontario was selected for this investment based on a strong competitive business environment, exceptional talent pool, and a government committed to fostering growth in the sector," said Ronnie Miller, president & CEO of Roche Pharmaceuticals, Canada. "We applaud the hard work done by the Government of Ontario and the Premier’s Office to foster a business environment that can compete internationally to attract investment opportunities, and Roche’s commitment to add up to 500 specialized positions is a direct result of these positive changes."

Roche says it will continue to invest in the Canadian healthcare ecosystem but needs the country to create a regulatory environment that will "help the sector and our citizens grow and thrive, while balancing system sustainability and equity."

Read the Roche statement